| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 2 | 24 | 2 | 12 | |
| BREAST | 1150 | 11 | 574 | 90 | 1096 | 171 | 1041 |
| ERLYTX | 86 | 1 | 52 | 7 | 85 | 15 | 91 |
| GI | 170 | 3 | 157 | 10 | 122 | 29 | 177 |
| GU | 343 | 8 | 417 | 35 | 426 | 76 | 463 |
| LEUK | 162 | 4 | 209 | 15 | 183 | 37 | 225 |
| LUNG | 210 | 2 | 104 | 20 | 244 | 42 | 256 |
| LYMPH | 418 | 5 | 261 | 29 | 353 | 74 | 450 |
| MELAN | 48 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 118 | 3 | 157 | 10 | 122 | 21 | 128 |
| MULT | 50 | 2 | 104 | 5 | 61 | 12 | 73 |
| OTHER | 55 | 1 | 52 | 3 | 37 | 7 | 43 |
| Total | 2812 | 40 | 2087 | 226 | 2753 | 486 | 2959 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 3 | 2 | 104 | 3 | 37 | 3 | 18 | |
| CCD | 183 | 3 | 157 | 24 | 292 | 43 | 262 |
| ERLYTX | 5 | 0 | 0 | 1 | 12 | 1 | 6 |
| GU | 5 | 1 | 52 | 1 | 12 | 1 | 6 |
| LEUK | 621 | 11 | 574 | 49 | 597 | 101 | 615 |
| LUNG | 379 | 8 | 417 | 33 | 402 | 58 | 353 |
| OTHER | 12 | 0 | 0 | 0 | 0 | 1 | 6 |
| PEOLC | 94 | 3 | 157 | 4 | 49 | 8 | 49 |
| PREV | 250 | 3 | 157 | 13 | 158 | 45 | 274 |
| SXQOL | 655 | 21 | 1096 | 64 | 779 | 112 | 682 |
| Total | 2207 | 52 | 2714 | 192 | 2338 | 373 | 2271 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 5 | 2 | 104 | 5 | 61 | 5 | 30 | |
| BREAST | 1150 | 11 | 574 | 90 | 1096 | 171 | 1041 |
| CCD | 183 | 3 | 157 | 24 | 292 | 43 | 262 |
| ERLYTX | 91 | 1 | 52 | 8 | 97 | 16 | 97 |
| GI | 170 | 3 | 157 | 10 | 122 | 29 | 177 |
| GU | 348 | 9 | 470 | 36 | 438 | 77 | 469 |
| LEUK | 783 | 15 | 783 | 64 | 779 | 138 | 840 |
| LUNG | 589 | 10 | 522 | 53 | 645 | 100 | 609 |
| LYMPH | 418 | 5 | 261 | 29 | 353 | 74 | 450 |
| MELAN | 48 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 118 | 3 | 157 | 10 | 122 | 21 | 128 |
| MULT | 50 | 2 | 104 | 5 | 61 | 12 | 73 |
| OTHER | 67 | 1 | 52 | 3 | 37 | 8 | 49 |
| PEOLC | 94 | 3 | 157 | 4 | 49 | 8 | 49 |
| PREV | 250 | 3 | 157 | 13 | 158 | 45 | 274 |
| SXQOL | 655 | 21 | 1096 | 64 | 779 | 112 | 682 |
| Total | 5019 | 92 | 4803 | 418 | 5089 | 859 | 5230 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 2 | 24 | 2 | 12 | |
| BREAST | 713 | 7 | 365 | 57 | 694 | 97 | 590 |
| ERLYTX | 56 | 1 | 52 | 6 | 73 | 11 | 67 |
| GI | 128 | 2 | 104 | 8 | 97 | 22 | 134 |
| GU | 262 | 7 | 365 | 25 | 304 | 56 | 341 |
| LEUK | 101 | 3 | 157 | 9 | 110 | 24 | 146 |
| LUNG | 129 | 1 | 52 | 11 | 134 | 25 | 152 |
| LYMPH | 274 | 3 | 157 | 18 | 219 | 48 | 292 |
| MELAN | 31 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 69 | 3 | 157 | 8 | 97 | 13 | 79 |
| MULT | 20 | 1 | 52 | 3 | 37 | 6 | 37 |
| OTHER | 54 | 0 | 0 | 2 | 24 | 6 | 37 |
| Total | 1839 | 28 | 1461 | 149 | 1813 | 310 | 1887 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 3 | 2 | 104 | 3 | 37 | 3 | 18 | |
| CCD | 139 | 1 | 52 | 15 | 183 | 28 | 170 |
| ERLYTX | 5 | 0 | 0 | 1 | 12 | 1 | 6 |
| GU | 5 | 1 | 52 | 1 | 12 | 1 | 6 |
| LEUK | 265 | 4 | 209 | 19 | 231 | 43 | 262 |
| LUNG | 230 | 7 | 365 | 22 | 268 | 33 | 201 |
| OTHER | 12 | 0 | 0 | 0 | 0 | 1 | 6 |
| PEOLC | 73 | 3 | 157 | 4 | 49 | 8 | 49 |
| PREV | 250 | 3 | 157 | 13 | 158 | 45 | 274 |
| SXQOL | 480 | 14 | 730 | 46 | 560 | 77 | 469 |
| Total | 1462 | 35 | 1826 | 124 | 1510 | 240 | 1461 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 8 | 3 | 157 | 8 | 97 | 8 | 49 | |
| BREAST | 891 | 12 | 626 | 73 | 889 | 131 | 797 |
| CCD | 162 | 0 | 0 | 10 | 122 | 23 | 140 |
| ERLYTX | 61 | 1 | 52 | 7 | 85 | 12 | 73 |
| GI | 131 | 1 | 52 | 6 | 73 | 21 | 128 |
| GU | 298 | 8 | 417 | 29 | 353 | 59 | 359 |
| LEUK | 367 | 7 | 365 | 28 | 341 | 67 | 408 |
| LUNG | 383 | 10 | 522 | 38 | 463 | 62 | 377 |
| LYMPH | 274 | 3 | 157 | 18 | 219 | 48 | 292 |
| MELAN | 31 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 69 | 3 | 157 | 8 | 97 | 13 | 79 |
| MULT | 39 | 0 | 0 | 1 | 12 | 4 | 24 |
| OTHER | 160 | 0 | 0 | 2 | 24 | 7 | 43 |
| PEOLC | 73 | 0 | 0 | 4 | 49 | 7 | 43 |
| PREV | 250 | 3 | 157 | 13 | 158 | 45 | 274 |
| SXQOL | 480 | 14 | 730 | 46 | 560 | 77 | 469 |
| Total | 3677 | 65 | 3392 | 291 | 3542 | 584 | 3555 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 976 | 9 | 470 | 83 | 1011 | 157 | 956 |
| ERLYTX | 81 | 1 | 52 | 7 | 85 | 15 | 91 |
| GI | 100 | 1 | 52 | 4 | 49 | 17 | 103 |
| GU | 242 | 6 | 313 | 26 | 317 | 55 | 335 |
| LEUK | 130 | 3 | 157 | 13 | 158 | 32 | 195 |
| LUNG | 183 | 1 | 52 | 17 | 207 | 38 | 231 |
| LYMPH | 352 | 5 | 261 | 26 | 317 | 63 | 384 |
| MMYEL | 103 | 2 | 104 | 8 | 97 | 19 | 116 |
| MULT | 50 | 2 | 104 | 5 | 61 | 12 | 73 |
| Total | 2217 | 30 | 1565 | 189 | 2302 | 408 | 2484 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1936 | 41 | 2139 | 150 | 1826 | 314 | 1911 |
| AFFIL | 141 | 2 | 104 | 7 | 85 | 21 | 128 |
| CCOP/NCORP | 1224 | 20 | 1044 | 116 | 1412 | 215 | 1309 |
| Non-SWOG | 1717 | 28 | 1461 | 144 | 1753 | 308 | 1875 |
| Total | 5018 | 91 | 4748 | 417 | 5076 | 858 | 5223 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| LEUK | MM1OA-S04 | MyeloMATCH: AML, ASTX727 + Ven (28D v 14D) | 1 | Y | 22-JUL-26 |
| ERLYTX | S2505 | Sarcoma, Stg II-IIIB, Surg + Short vs Std RT | 1 | Y | 06-JUL-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| BREAST | MA39 | BREAST, Node-Pos, Reg RT vs No Reg RT | 1 | E | 30-JUN-26 |
| BREAST | MA39 | BREAST, Node-Pos, Reg RT vs No Reg RT | 2 | E | 30-JUN-26 |
| GI | S1922 | Small Bowel,Ram+Pac vs FOLFIRI, mets/unresect | 1 | N | 15-JUL-26 |
| ERLYTX | S2012 | Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo | 1 | T | 09-JUL-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 11 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 11 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 10 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 8 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 8 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 5 |
| SXQOL | NRGCC015 | E-Mindfulness After Breast Cancer | 1 | 5 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 5 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 5 |
| PEOLC | S1501 | Surv, Breast Stg IV, Card Tox w/ Carvedilol | 2 | 3 |